<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?><data_table id="pht001812.v2" study_id="phs000285.v3" participant_set="2" date_created="Tue Aug 20 16:10:43 2013"><variable id="phv00119990.v2"><name>Individual_ID</name><description>Subject Identifier</description><type>string</type></variable><variable id="phv00119991.v2"><name>F09ASPNO</name><description>NUMBER OF ASPIRINS TAKEN PER WEEK. Q 32a</description><type>integer</type><logical_min>1</logical_min><logical_max>55</logical_max><comment>Please consult the document athttp://www.cardia.dopm.uab.edu/study-information/nhlbi-data-repository-data/cardia-documentation</comment></variable><variable id="phv00119992.v2"><name>F09ASPRS</name><description>PURPOSE FOR TAKING ASPIRIN. Q 32b</description><type>encoded</type><comment>Please find encoded value descriptions in associated documents. Some of the values might be encoded and code descriptions have not been submitted at this time.
		Please consult the document athttp://www.cardia.dopm.uab.edu/study-information/nhlbi-data-repository-data/cardia-documentation. </comment><value code="1">Mentioned avoiding heart attack and/or stroke or thinning blood</value><value code="2">Did not mention avoiding heart attack and/ or stroke or thinning blood</value></variable><variable id="phv00119993.v2"><name>F09IEXDT</name><description>DATE OF EXAM-FORM 9 ASPIRIN</description><type>integer</type><logical_min>169</logical_min><logical_max>193</logical_max><comment>Please consult the document athttp://www.cardia.dopm.uab.edu/study-information/nhlbi-data-repository-data/cardia-documentation</comment></variable></data_table>
